The key takeaways from some recent blockbuster patentability cases from the Fed Circuit https://t.co/BT95Uj7Grz
Come and meet IP leaders from the Auto Industry to learn, share best practice and discuss new ways to exploit and p… https://t.co/K90wCUzwKd
Patent owners have little to worry about in JPO plans for SEP reviews. https://t.co/Cfp3RZOL1H
In the almost four years since the Supreme Court added to its jurisprudence around patentability in Alice Corp v CLS Bank, the Court of Appeals for the Federal Circuit (CAFC) has been steadily filling in the blanks on what exactly constitutes patent eligible subject matter - particularly when it comes to computer-implemented inventions. The court has tinkered less with the actual process...
JPO details plan to review SEP essentiality, but there may be little scope for implementers to use it defensively
The Japan Patent Office (JPO) last week unveiled a new service that will see it weigh in on the standing of Japanese patents declared standards essential. When it was first announced last November, this system was perceived as offering a defensive tool to implementers. But the draft guidelines for the scheme, helpfully translated in part here by Satoshi Watanabe of Watanabe Research and...
Poor patent quality, biosimilars, third-party disputes, Brexit and more from our pharma and biotech event
Last week, life sciences patent professionals from around the world gathered at London’s Hallam Conference Centre for IAM’s second annual Pharma and Biotech IP Summit – the first ever IAM event to be held on UK home turf. Delegates – and there were twice as many in attendance than were at our first summit in Munich in 2016 – were treated to insightful...
Artificial intelligence is creating a seismic shift in the way that people interact with technology. Research institutions and for-profit companies are moving to patent the commercial aspects of this new area in a land grab which could see rights holders reap future benefits
Peter Cowan and Jim Hinton
IAM Patent 1000
The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.Visit site